新型丙型肝炎病毒抑制剂索非布韦的中国专利申请状况分析

Analysis of patent application of the new HCV inhibitor sofosbuvir in China

本文对新型丙型肝炎病毒(hepatitis C virus,HCV)抑制剂索非布韦在中国的专利申请状况进行分析,重点涉及专利申请的时间分布情况、专利申请人情况、专利申请的法律状态、原研公司的专利布局以及其他申请人有关索非布韦的外围专利申请情况等,旨在为国内研究机构和制药企业提供有益的研究方向和在专利布局方面的建议。

In this paper,we analyzed the patent applications of the new HCV inhibitor sofosbuvir in China,mainly focusing on the time distribution,patent applicants and legal status of the patent applications,patent distribution of the original company,as well as other applicants＇ patent applications related to sofosbuvir. This paper may provide beneficial research directions and suggestions in terms of patent distribution to domestic research institutions and pharmaceutical companies.